Previous Page  50 / 102 Next Page
Information
Show Menu
Previous Page 50 / 102 Next Page
Page Background

Cuba

Continued

[ 46 ]

TOBACCO BUSINESS

[

SEPTEMBER

/

OCTOBER

|

17 ]

The feedback we’re getting on the brand

ambassadors is very favorable. Retailers appre-

ciate the engagement we’re offering in their

shops, and cigar lovers are following along

on social media, learning not only about the

brands, but checking in to see where the brand

ambassadors will be next.

ON NAVIGATING FDA REGULATION…

How has the U.S.’s regulatory envi-

ronment impacted strategic planning

during your tenure at General Cigar?

We’re the swan above the water, paddling

like hell underneath. With the FDA regula-

tions, it’s essential that we keep on developing

the brand equities and keep our retailers and

consumers excited about what’s in store. Yes,

it did change our strategic planning as it has

put more restraints on us, but those are the

boundaries we have to operate in for now—

and we are.

One of the learnings we had when in Europe

and when the TPD2 [revised EU Tobacco

Products Directive] legislation hit us was that

we focused solely on becoming TPD2 compli-

ant. We forgot to innovate, to develop, to excite

and to build. That caught up with us when we

came out of the TPD2 compliance phase. I was

committed to not letting that happen again. We

ran and still are running two parallel paths: one

being FDA compliance and the other being

developing and winning—exciting the hearts

and minds of the retailer and consumers. It has

put a tremendous pressure on our teams, but

they pulled through and have done a fantas-

tic job. And it is paying off. We live by dream-

ing big, getting shit done and having fun at the

same time.

Within the industry, there’s talk that

the regulatory environment will stifle

development of new cigars and that

the industry will consolidate as com-

panies struggle to comply with FDA

regulation. How will General Cigar

continue to innovate and market

under FDA regulation?

As I mentioned before, we have a library of

predicate cigar blends that is unmatched in

the handmade cigar category. This library of

FDA-compliant predicate cigar blends gives

us all the resources that we need to keep on

surprising our consumers and retailers. As

far as marketing, our strategy is clear. We will

continue to solicit feedback from brick-and-

mortar retailers and will respond to the chang-

ing needs of the retail environment with the

right new items. We’ll leverage our feet on the

street to support our brands at the retail level,

and [we] will continue to deliver meaningful

experiences and engagements with our brands.

I do also believe that the flood of innovation

each year has prevented companies and retail-

ers from really building a sustainable and loy-

al consumer base. With the flood of innova-

tions, brand loyalty has diminished. The first

question a consumer asks when coming into a

store is, “What’s new?” There are hundreds

of cigars in the store already, but the flood of

innovation has taken away the attention from

building a strong core of brands and driving

continuous trial. Every strong company and

industry needs a strong core, and GCC is

providing that.

What do you think the cigar

market will look like in five years?

I believe there will be consolidation in the mar-

ketplace, and the companies that consistent-

ly make quality cigars that meet retailer and

consumer needs and build and support their

brands will continue to thrive. It’s all about

brand equity and being relevant. GCC will

assure that.

TB

For more on General Cigar’s new releases, which

include Macanudo, CAO (Amazon Anaconda),

Partagás, Cohiba, Foundry and La Gloria Cubana

(Coleccion Reserva), see IPCPR Insights, p.12.

We ran and still are running two parallel

paths: one being FDA compliance

and the other being developing and

winning—exciting the hearts and minds

of the retailer and consumers.

Regis

Continued